CN Patent

CN112724156B — 一种多环吡啶酮衍生物和药物组合物及其应用

Assigned to Shenzhen Berry Biomedical Technology Co ltd · Expires 2022-05-10 · 4y expired

What this patent protects

本发明属于药物领域，涉及一种多环吡啶酮衍生物和药物组合物及其应用。该多环吡啶酮衍生物为式(I)所示化合物或式(I)所示化合物的立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它们的前药。与已有的同类化合物相比，本发明的化合物不仅能很好的抑制流感病毒的复制，还具有更低的细胞毒性。

USPTO Abstract

本发明属于药物领域，涉及一种多环吡啶酮衍生物和药物组合物及其应用。该多环吡啶酮衍生物为式(I)所示化合物或式(I)所示化合物的立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它们的前药。与已有的同类化合物相比，本发明的化合物不仅能很好的抑制流感病毒的复制，还具有更低的细胞毒性。

Drugs covered by this patent

Patent Metadata

Patent number
CN112724156B
Jurisdiction
CN
Classification
—
Expires
2022-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Berry Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.